BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 8240594)

  • 1. Severe hemolytic disease of the newborn caused by anti-Gonzales antibody.
    Leschek E; Pearlman SA; Boudreaux I; Meek R
    Am J Perinatol; 1993 Sep; 10(5):362-4. PubMed ID: 8240594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-E as a cause of hemolytic disease of the newborn.
    Cheepsattayakorn R; Fongsatitkul L; Chotinaruemol S; Mahawongtong M
    J Med Assoc Thai; 1997 Sep; 80 Suppl 1():S1-4. PubMed ID: 9347637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Review of positive direct antiglobulin tests found on cord blood sampling.
    Dinesh D
    J Paediatr Child Health; 2005; 41(9-10):504-7. PubMed ID: 16150068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Haemolytic disease of the newborn--from a mother with anti-Kell, anti-E and anti-Vel anti-erythrocyte alloantibodies].
    Vućinović M; Jadrić H; Karelović D; Roje D; Haspl-Hundrić Z; Hrgović Z; Vućinović Z
    Z Geburtshilfe Neonatol; 2004 Oct; 208(5):197-202. PubMed ID: 15508054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of single versus double volume exchange transfusion in newborn infants with AB0 hemolytic disease.
    Amato M; Blumberg A; Hermann U; Zurbrügg R
    Helv Paediatr Acta; 1988 Nov; 43(3):177-86. PubMed ID: 3220789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemolytic disease of the newborn due to isoimmunization with anti-E antibodies: a case report.
    Sarici SU; Alpay F; Yeşilkaya E; Ozcan O; Gökçay E
    Turk J Pediatr; 2002; 44(3):248-50. PubMed ID: 12405439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravenous immunoglobulin G (IVIG) therapy for significant hyperbilirubinemia in ABO hemolytic disease of the newborn.
    Miqdad AM; Abdelbasit OB; Shaheed MM; Seidahmed MZ; Abomelha AM; Arcala OP
    J Matern Fetal Neonatal Med; 2004 Sep; 16(3):163-6. PubMed ID: 15590442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Severe intrauterine hemolysis due to anti-C(w).
    Chu HP; Kanagalingam D; Chan DK
    Am J Perinatol; 2007 Nov; 24(10):623-6. PubMed ID: 17972235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recurrence rate of ABO hemolytic disease of the newborn.
    Katz MA; Kanto WP; Korotkin JH
    Obstet Gynecol; 1982 May; 59(5):611-4. PubMed ID: 7070734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of screening for red cell antibodies, other than anti-D, to detect hemolytic disease of the fetus and newborn: a population study in the Netherlands.
    Koelewijn JM; Vrijkotte TG; van der Schoot CE; Bonsel GJ; de Haas M
    Transfusion; 2008 May; 48(5):941-52. PubMed ID: 18248570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemolytic disease of the newborn caused by irregular blood subgroup (Kell, C, c, E, and e) incompatibilities: report of 106 cases at a tertiary-care centre.
    Karagol BS; Zenciroglu A; Okumus N; Karadag N; Dursun A; Hakan N
    Am J Perinatol; 2012 Jun; 29(6):449-54. PubMed ID: 22399212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A case of severe hemolytic disease of the newborn due to anti-Dia antibody].
    Lee SM; Im SJ; Park SE; Lee EY; Kim HH
    Korean J Lab Med; 2007 Oct; 27(5):373-6. PubMed ID: 18094604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Delayed hemolytic transfusion reaction due to anti-Go(a), an antibody against the low-prevalence Gonzales antigen.
    Larson PJ; Lukas MB; Friedman DF; Manno CS
    Am J Hematol; 1996 Dec; 53(4):248-50. PubMed ID: 8948664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RhD haemolytic disease of the fetus and the newborn.
    Urbaniak SJ; Greiss MA
    Blood Rev; 2000 Mar; 14(1):44-61. PubMed ID: 10805260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemolytic disease of the newborn from anti-E. A case report.
    Strohm PL; Iams JD; Kennedy MS
    J Reprod Med; 1988 Apr; 33(4):404-6. PubMed ID: 3130484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hemolytic disease of the newborn caused by maternal anti-Di(a): a case report in Taiwan].
    Yung CH; Lin JS; Hu HY; Lyou JY; Chen YR; Chen CR; Hao TC; Peng CS; Tzeng CH
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1995 May; 28(2):146-50. PubMed ID: 9774993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Perinatal management and neurological outcome of newborns hospitalized with Rhesus hemolytic disease].
    Gobalakichenane P; Lardennois C; Galène-Gromez S; Brossard V; Marpeau L; Verspyck E; Marret S;
    Gynecol Obstet Fertil; 2008 Oct; 36(10):984-90. PubMed ID: 18804397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Rhesus-erythroblastosis. Diagnosis, therapy, prevention].
    Maas DH; Schneider J
    Fortschr Med; 1976 May; 94(13):735-40. PubMed ID: 821837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation and treatment of jaundice in the term newborn: a kinder, gentler approach.
    Newman TB; Maisels MJ
    Pediatrics; 1992 May; 89(5 Pt 1):809-18. PubMed ID: 1579380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Severe hemolytic disease of the newborn from anti-e.
    McAdams RM; Dotzler SA; Winter LW; Kerecman JD
    J Perinatol; 2008 Mar; 28(3):230-2. PubMed ID: 18309317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.